Rupert Vessey, MA, BM BCh, FRCP, DPhil
Dr. Vessey serves as President of Research and Early Development. He joined Celgene Corporation in January 2015 as Senior Vice President, Translational Development. Before joining Celgene, Dr. Vessey was Senior Vice President of Early Development and Discovery Sciences at Merck. During his ten years with Merck, Dr. Vessey was responsible for numerous drug development programs and served as Senior Vice President, Early Development and Discovery Sciences, Senior Vice President, Respiratory and Immunology Franchise and Vice President, Drug Discovery and Informatics. Prior to Merck, he spent five years at GlaxoSmithKline in drug discovery, experimental medicine and early clinical development of therapeutics for respiratory and immune diseases. Dr. Vessey graduated from Oxford University with degrees in Physiological Sciences (M.A.), Clinical Medicine (B.M., B.Ch.) and a D.Phil. (Ph.D.) in Molecular Immunology. He is an elected Fellow of the Royal College of Physicians.